@ARTICLE{
author={Vukovic Petar G,Jeremic Aleksandra,Vezmar Milica,Milosavljevic Filip,Pavlovic Zorana Z,Pesic Danilo R,Drakulic-Djordjevic Jelena,Pejuskovic Bojana,Markovic Bojan D,Ingelman-Sundberg Magnus,Miljevic Cedo D,Maric Nadja P,Jukic Marin M},
year={2026},
title={Perceived stress four weeks after initiation of escitalopram monotherapy as a predictor of anxiolytic and antidepressant effects},
journal={JOURNAL OF AFFECTIVE DISORDERS},
volume={403},
number={},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Vukovic Petar G,Jeremic Aleksandra,Vezmar Milica,Milosavljevic Filip,Pavlovic Zorana Z,Pesic Danilo R,Drakulic-Djordjevic Jelena,Pejuskovic Bojana,Markovic Bojan D,Ingelman-Sundberg Magnus,Miljevic Cedo D,Maric Nadja P,Jukic Marin M},
year={2025},
title={Effectiveness and safety of escitalopram treatment personalized based on therapeutic drug monitoring of drug plasma concentration: a prospective cohort study},
journal={SCIENTIFIC REPORTS},
volume={15},
number={1},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Manojlovic Marina,Milosavljevic Filip,Atanasov Andrea,Batinic Bojan A,Sitarica Pavle,Pesic Vesna,Jukic Marin M},
year={2024},
title={Social isolation during adolescence causes increased generalised anxiety-like behaviour in male rats and increased sociability in male and female rats},
journal={NEUROSCIENCE APPLIED},
volume={3},
number={},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Vukovic Petar G,Jeremic A,Vezmar Milica,Pesic Danilo R,Pejuskovic Bojana,Drakulic-Djordjevic Jelena,Milosavljevic Filip,Miljevic Cedo D,Maric-Bojovic Nadja P,Markovic Bojan D,Ingelman Sundberg Magnus,Jukic Marin M},
year={2024},
title={Association between escitalopram dose personalisation based on quantification of drug plasma levels and the outcome of escitalopram treatment},
journal={EUROPEAN PSYCHIATRY},
volume={67},
number={},
pages={S44-S45},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Milosavljevic Filip,Manojlovic Marina,Matkovic Lena,Molden Espen,Ingelman Sundberg Magnus,Leucht Stefan,Jukic Marin M},
year={2024},
title={Pharmacogenetic Variants and Plasma Concentrations of Antiseizure Drugs},
journal={JAMA NETWORK OPEN},
volume={7},
number={8},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Milosavljevic Filip,Molden Espen,Ingelman Sundberg Magnus,Jukic Marin M},
year={2024},
title={Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized controlled clinical trials},
journal={EUROPEAN NEUROPSYCHOPHARMACOLOGY},
volume={81},
number={},
pages={43-52},
document_type={Review},
} 

@ARTICLE{
author={Milosavljevic Filip,...,Atanasov Andrea,Manojlovic Marina,Vucic Marija,Orescanin-Dusic Zorana S,Brkljacic Jelena B,Miljevic Cedo D,Nikolic-Kokic Aleksandra L,Blagojevic Dusko P,...,Pesic Vesna,...,Jukic Marin M},
year={2023},
title={The humanised <i>CYP2C19</i> transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxia},
journal={NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY},
volume={49},
number={1},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Jukic Marin M,Milosavljevic Filip,Molden Espen,Ingelman-Sundberg Magnus},
year={2022},
title={Pharmacogenomics in treatment of depression and psychosis: an update},
journal={TRENDS IN PHARMACOLOGICAL SCIENCES},
volume={43},
number={12},
pages={1055-1069},
document_type={Review},
} 

@ARTICLE{
author={Jokovic Danilo B,Milosavljevic Filip,Stojanovic Zvezdana B,Supic Gordana M,Vojvodic Danilo V,Uzelac Bojana,Jukic Marin M,Petkovic-Curcin Aleksandra B},
year={2022},
title={CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability},
journal={PSYCHIATRY RESEARCH},
volume={312},
number={},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Pridgeon Chris S,Bolhuis Dian P,Milosavljevic Filip,Manojlovic Marina,Vegvari Akos,Gaetani Massimiliano,Jukic Marin M,Ingelman-Sundberg Magnus},
year={2022},
title={Hepatocyte Thorns, A Novel Drug-Induced Stress Response in Human and Mouse Liver Spheroids},
journal={CELLS},
volume={11},
number={10},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Milosavljevic Filip,Bukvic Nikola,Pavlovic Zorana Z,Miljevic Cedo D,Pesic Vesna,Molden Espen,Ingelman-Sundberg Magnus,Leucht Stefan,Jukic Marin M},
year={2021},
title={Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure A Systematic Review and Meta-analysis},
journal={JAMA PSYCHIATRY},
volume={78},
number={3},
pages={270-280},
document_type={Review},
} 

@ARTICLE{
author={Milosavljevic Filip,Bukvic Nikola,Pavlovic Zorana Z,Miljevic Cedo D,Pesic Vesna,Molden Espen,Ingelman-Sundberg Magnus,Leucht Stefan,Jukic Marin M},
year={2020},
title={Impact of CYP2C19 and CYP2D6 polymorphism on antidepressants and antipsychotics exposure; a meta-analysis},
journal={EUROPEAN NEUROPSYCHOPHARMACOLOGY},
volume={40},
number={},
pages={S250-S251},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Milosavljevic Filip,Vucic Marija,Manojlovic M,Milosevski T,Batinic Bojan A,Novalen M,Miksys S,Tyndale FR,Ingelman-Sundberg Magnus,Pesic Vesna,Jukic Marin M},
year={2020},
title={Reduced cerebellum volume and ataxia-like motoric phenotype in transgenic mouse, carrier of human CYP2C19 gene},
journal={EUROPEAN NEUROPSYCHOPHARMACOLOGY},
volume={40},
number={},
pages={S208-S208},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Kapor Slobodan,Aksic Milan Z,Puskas Laslo A,Jukic Marin M,Poleksic Joko Lj,Milosavljevic Filip,Bjelica Suncica,Filipovic Branislav R},
year={2020},
title={Long-Term Effects of Maternal Deprivation on the Volume of Dopaminergic Nuclei and Number of Dopaminergic Neurons in Substantia Nigra and Ventral Tegmental Area in Rats},
journal={FRONTIERS IN NEUROANATOMY},
volume={14},
number={},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Milosavljevic Filip,Bukvic Nikola,Pesic Vesna,Molden Espen,Ingelman-Sundberg Magnus,Jukic Marin M},
year={2019},
title={Quantification of antidepressant and antipsychotic exposure increase caused by CYP2C19 and CYP2D6 intermediate and poor metabolizer status by meta-analysis},
journal={EUROPEAN NEUROPSYCHOPHARMACOLOGY},
volume={29},
number={},
pages={S533-S534},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Milosavljevic Filip,Vucic Marija,Manojlovic M,Asujic N,Batinic Bojan A,Novalen M,Miksys S,Tyndale RF,Ingelman-Sundberg Magnus,Jukic Marin M},
year={2019},
title={Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia},
journal={EUROPEAN NEUROPSYCHOPHARMACOLOGY},
volume={29},
number={},
pages={S399-S400},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Milosavljevic Filip,Vucic Marija,Manojlovic M,Asujic N,Batinic Bojan A,Novalen M,Miksys S,Tyndale RF,Ingelman-Sundberg Magnus,Pesic Vesna,Jukic Marin M},
year={2019},
title={Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia},
journal={EUROPEAN NEUROPSYCHOPHARMACOLOGY},
volume={29},
number={},
pages={S17-S17},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Milosavljevic Filip,Vucic Marija,Manojlovic M,Asujic N,Batinic Bojan A,Novalen M,Miksys S,Tyndale RF,Ingelman-Sundberg Magnus,Pesic Vesna,Jukic Marin M},
year={2019},
title={Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia},
journal={EUROPEAN NEUROPSYCHOPHARMACOLOGY},
volume={29},
number={},
pages={S672-S673},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Baralic Katarina V,Curcic Marijana M,Antonijevic Evica Lj,Bulat Zorica L,Jankovic Sasa D,Todorovic Milica,Milosavljevic Filip,Kotur-Stevuljevic Jelena M,Kalimanovska Vesna V,Matovic Vesna,Antonijevic Biljana,Djukic-Cosic Danijela D},
year={2017},
title={Obesity in relation with erythrocyte lead level in people exposed to environmental lead in Belgrade, Serbia},
journal={TOXICOLOGY LETTERS},
volume={280},
number={},
pages={S179-S179},
document_type={Meeting Abstract},
}